317 related articles for article (PubMed ID: 15246109)
1. Structure, stability and interactions of type I collagen with GLY349-CYS substitution in alpha 1(I) chain in a murine Osteogenesis Imperfecta model.
Kuznetsova NV; Forlino A; Cabral WA; Marini JC; Leikin S
Matrix Biol; 2004 May; 23(2):101-12. PubMed ID: 15246109
[TBL] [Abstract][Full Text] [Related]
2. Selective retention and degradation of molecules with a single mutant alpha1(I) chain in the Brtl IV mouse model of OI.
Forlino A; Kuznetsova NV; Marini JC; Leikin S
Matrix Biol; 2007 Oct; 26(8):604-14. PubMed ID: 17662583
[TBL] [Abstract][Full Text] [Related]
3. Y-position cysteine substitution in type I collagen (alpha1(I) R888C/p.R1066C) is associated with osteogenesis imperfecta/Ehlers-Danlos syndrome phenotype.
Cabral WA; Makareeva E; Letocha AD; Scribanu N; Fertala A; Steplewski A; Keene DR; Persikov AV; Leikin S; Marini JC
Hum Mutat; 2007 Apr; 28(4):396-405. PubMed ID: 17206620
[TBL] [Abstract][Full Text] [Related]
4. Altered collagen structure in mouse tail tendon lacking the alpha 2(I) chain.
McBride DJ; Choe V; Shapiro JR; Brodsky B
J Mol Biol; 1997 Jul; 270(2):275-84. PubMed ID: 9236128
[TBL] [Abstract][Full Text] [Related]
5. A novel Gly to Arg substitution at position 388 of the alpha1 chain of type I collagen in lethal form of osteogenesis imperfecta.
Galicka A; Wolczynski S; Lesniewicz R; Chyczewski L; Gindzienski A
Acta Biochim Pol; 2002; 49(2):443-50. PubMed ID: 12362986
[TBL] [Abstract][Full Text] [Related]
6. Severity of osteogenesis imperfecta and structure of a collagen-like peptide modeling a lethal mutation site.
Radmer RJ; Klein TE
Biochemistry; 2004 May; 43(18):5314-23. PubMed ID: 15122897
[TBL] [Abstract][Full Text] [Related]
7. Properties of collagen in OIM mouse tissues.
Sims TJ; Miles CA; Bailey AJ; Camacho NP
Connect Tissue Res; 2003; 44 Suppl 1():202-5. PubMed ID: 12952198
[TBL] [Abstract][Full Text] [Related]
8. Osteogenesis imperfecta murine: interaction between type I collagen homotrimers.
Kuznetsova N; McBride DJ; Leikin S
J Mol Biol; 2001 Jun; 309(3):807-15. PubMed ID: 11397098
[TBL] [Abstract][Full Text] [Related]
9. Predicting the clinical lethality of osteogenesis imperfecta from collagen glycine mutations.
Bodian DL; Madhan B; Brodsky B; Klein TE
Biochemistry; 2008 May; 47(19):5424-32. PubMed ID: 18412368
[TBL] [Abstract][Full Text] [Related]
10. Synthetic collagen heterotrimers: structural mimics of wild-type and mutant collagen type I.
Gauba V; Hartgerink JD
J Am Chem Soc; 2008 Jun; 130(23):7509-15. PubMed ID: 18481852
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of both extracellular and intracellular proteins is involved in the lethal or nonlethal phenotypic variation of BrtlIV, a murine model for osteogenesis imperfecta.
Forlino A; Tani C; Rossi A; Lupi A; Campari E; Gualeni B; Bianchi L; Armini A; Cetta G; Bini L; Marini JC
Proteomics; 2007 Jun; 7(11):1877-91. PubMed ID: 17520686
[TBL] [Abstract][Full Text] [Related]
12. Studies on type I collagen in skin fibroblasts cultured from twins with lethal osteogenesis imperfecta.
Galicka A; Wołczyński S; Gindzieński A
Acta Biochim Pol; 2003; 50(2):481-8. PubMed ID: 12833172
[TBL] [Abstract][Full Text] [Related]
13. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood.
Malfait F; Symoens S; De Backer J; Hermanns-Lê T; Sakalihasan N; Lapière CM; Coucke P; De Paepe A
Hum Mutat; 2007 Apr; 28(4):387-95. PubMed ID: 17211858
[TBL] [Abstract][Full Text] [Related]
14. (G586V) substitutions in the alpha 1 and alpha 2 chains of collagen I: effect of alpha-chain stoichiometry on the phenotype of osteogenesis imperfecta?
Lund AM; Skovby F; Schwartz M
Hum Mutat; 1997; 9(5):431-6. PubMed ID: 9143923
[TBL] [Abstract][Full Text] [Related]
15. Comparative studies of osteoblast and fibroblast type I collagen in a patient with osteogenesis imperfecta type IV.
Galicka A; Wolczynski S; Gindzienski A
J Pathol; 2002 Feb; 196(2):235-7. PubMed ID: 11793376
[TBL] [Abstract][Full Text] [Related]
16. Type I collagen triplet duplication mutation in lethal osteogenesis imperfecta shifts register of alpha chains throughout the helix and disrupts incorporation of mutant helices into fibrils and extracellular matrix.
Cabral WA; Mertts MV; Makareeva E; Colige A; Tekin M; Pandya A; Leikin S; Marini JC
J Biol Chem; 2003 Mar; 278(12):10006-12. PubMed ID: 12538651
[TBL] [Abstract][Full Text] [Related]
17. Changes in thermal stability and microunfolding pattern of collagen helix resulting from the loss of alpha2(I) chain in osteogenesis imperfecta murine.
Kuznetsova NV; McBride DJ; Leikin S
J Mol Biol; 2003 Aug; 331(1):191-200. PubMed ID: 12875845
[TBL] [Abstract][Full Text] [Related]
18. Biochemical screening of type I collagen in osteogenesis imperfecta: detection of glycine substitutions in the amino end of the alpha chains requires supplementation by molecular analysis.
Cabral WA; Milgrom S; Letocha AD; Moriarty E; Marini JC
J Med Genet; 2006 Aug; 43(8):685-90. PubMed ID: 16882741
[TBL] [Abstract][Full Text] [Related]
19. Destabilization of osteogenesis imperfecta collagen-like model peptides correlates with the identity of the residue replacing glycine.
Beck K; Chan VC; Shenoy N; Kirkpatrick A; Ramshaw JA; Brodsky B
Proc Natl Acad Sci U S A; 2000 Apr; 97(8):4273-8. PubMed ID: 10725403
[TBL] [Abstract][Full Text] [Related]
20. Deletions and duplications of Gly-Xaa-Yaa triplet repeats in the triple helical domains of type I collagen chains disrupt helix formation and result in several types of osteogenesis imperfecta.
Pace JM; Atkinson M; Willing MC; Wallis G; Byers PH
Hum Mutat; 2001 Oct; 18(4):319-26. PubMed ID: 11668615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
